Published in Neurology on April 08, 2003
Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol (2008) 1.87
Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimers Res Ther (2010) 1.39
Dehydroepiandrosterone and age-related cognitive decline. Age (Dordr) (2009) 0.93
Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study. Psychopharmacology (Berl) (2005) 0.93
Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. J Clin Endocrinol Metab (2008) 0.83
DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial. Neurology (2004) 0.76
Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately? Open Neurol J (2009) 0.75
Enhancement of Cognitive and Electrophysiological Measures of Hippocampal Functioning in Rats by a Low, But Not High, Dose of Dehydroepiandrosterone Sulfate (DHEAS). Nonlinearity Biol Toxicol Med (2004) 0.75
DHEA for Alzheimer's disease: a modest showing by a superhormone. Neurology (2003) 0.75
In rats, oral oleoyl-DHEA is rapidly hydrolysed and converted to DHEA-sulphate. BMC Pharmacol (2007) 0.75
The borderland between normal aging and dementia. Ci Ji Yi Xue Za Zhi (2017) 0.75
On a Back Cross in Mice Involving Three Allelomorphic Pairs of Characters. Genetics (1918) 6.12
Central obesity and increased risk of dementia more than three decades later. Neurology (2008) 6.03
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2009) 5.94
Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol (1998) 5.42
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 5.12
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12
Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology (2002) 5.03
Twenty five years of case finding and audit in a socially deprived community. BMJ (1991) 4.89
Situs inversus and embryonic ciliary morphogenesis defects in mouse mutants lacking the KIF3A subunit of kinesin-II. Proc Natl Acad Sci U S A (1999) 4.11
Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71
Are amyotrophic lateral sclerosis patients cognitively normal? Neurology (2003) 3.21
Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med (1996) 3.20
Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology (2007) 3.18
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01
Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology (2009) 2.92
Longitudinal volumetric MRI change and rate of cognitive decline. Neurology (2005) 2.90
Cognitive effects of corticosteroids. Am J Psychiatry (1990) 2.85
Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology (2004) 2.83
Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med (2000) 2.81
Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry (1998) 2.77
Functional importance of conserved domains in the flowering-time gene CONSTANS demonstrated by analysis of mutant alleles and transgenic plants. Plant J (2001) 2.69
Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry (1998) 2.69
A relatively minor adult case becomes significantly complex: A lesson in humility. Am J Orthod Dentofacial Orthop (2001) 2.68
Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc (1999) 2.63
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology (1998) 2.61
The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med (1991) 2.48
Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer. Lancet (1995) 2.45
Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology (2004) 2.37
Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology (2002) 2.35
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33
Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol (1973) 2.31
Conceptualization and measurement of quality of life in dementia: the dementia quality of life instrument (DQoL). Gerontologist (1999) 2.29
The natural history of temporal variant frontotemporal dementia. Neurology (2005) 2.22
Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.12
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology (2001) 2.11
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology (2000) 2.10
Genital herpetic infection. Association with cervical dysplasia and carcinoma. Cancer (1969) 2.10
Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology (2005) 2.10
Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol (1994) 2.03
A new method for autozygosity mapping using single nucleotide polymorphisms (SNPs) and EXCLUDEAR. J Med Genet (2004) 2.02
Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2008) 2.00
Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol (1996) 1.96
Fractional utilization of the aerobic capacity during distance running. Med Sci Sports (1973) 1.93
A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology (2005) 1.93
Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst (2000) 1.92
A third novel locus for primary autosomal recessive microcephaly maps to chromosome 9q34. Am J Hum Genet (2000) 1.91
The association between sleep duration and obesity in older adults. Int J Obes (Lond) (2008) 1.89
Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88
Mutations in WNT7A cause a range of limb malformations, including Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome. Am J Hum Genet (2006) 1.85
Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology (2000) 1.82
Biochemical-physiological correlations in studies of the gamma-aminobutyric acid system. Brain Res (1968) 1.80
Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations. Biotechniques (2002) 1.80
Executive function, memory, and gait speed decline in well-functioning older adults. J Gerontol A Biol Sci Med Sci (2010) 1.80
Three distinct DNA ligases in mammalian cells. J Biol Chem (1991) 1.79
Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology (2006) 1.78
Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology (1997) 1.77
A carbon-phosphorus bond in nature. Science (1969) 1.77
Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23. Nat Genet (1996) 1.76
Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology (2000) 1.76
Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc (1999) 1.73
Development of major depression after treatment for smoking cessation. Am J Psychiatry (2000) 1.72
GABA neurons are the major cell type of the nucleus reticularis thalami. Brain Res (1980) 1.72
Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J Consult Clin Psychol (1988) 1.71
Cognitive function and retinal and ischemic brain changes: the Women's Health Initiative. Neurology (2012) 1.68
Use of linkage disequilibrium approaches to map genes for bipolar disorder in the Costa Rican population. Am J Med Genet (1996) 1.65
Cloning of Drosophila choline acetyltransferase cDNA. Proc Natl Acad Sci U S A (1986) 1.65
Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology (2004) 1.64
Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry (1989) 1.64
Nicotine, negative affect, and depression. J Consult Clin Psychol (1993) 1.64
Dietary sodium restriction for mild hypertension in general practice. Br Med J (Clin Res Ed) (1983) 1.62
The association between head trauma and Alzheimer's disease. Am J Epidemiol (1990) 1.58
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry (1999) 1.57
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. N Engl J Med (1999) 1.55
Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. Am J Hum Genet (1999) 1.54
Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. J Med Genet (2003) 1.53
Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res (1996) 1.53
Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease. Int J Clin Pract (2010) 1.51
Identification of potential CSF biomarkers in ALS. Neurology (2006) 1.50
A comparison of the effects of rectangular and round arch wires in leveling the curve of Spee. Am J Orthod Dentofacial Orthop (1999) 1.49
The fine structural localization of glutamate decarboxylase in synaptic terminals of rodent cerebellum. Brain Res (1974) 1.48
Resolution of mandibular arch crowding in growing patients with Class I malocclusions treated nonextraction. Am J Orthod Dentofacial Orthop (1996) 1.46
A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci U S A (1996) 1.46
Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci U S A (1992) 1.46
A fifth locus for primary autosomal recessive microcephaly maps to chromosome 1q31. Am J Hum Genet (2000) 1.45
Self awareness and personality change in dementia. J Neurol Neurosurg Psychiatry (2005) 1.45
Hemispheric dominance for emotions, empathy and social behaviour: evidence from right and left handers with frontotemporal dementia. Neurocase (2001) 1.44
Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. Headache (2001) 1.43
Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology (2007) 1.43
The survival of Class V restorations in general dental practice: part 3, five-year survival. Br Dent J (2012) 1.42
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer. Br J Cancer (1996) 1.40